91 related articles for article (PubMed ID: 21076498)
1. Chloroethyl urea derivatives block tumour growth and thioredoxin-1 nuclear translocation.
Patenaude A; Fortin JS; Deschenes R; Côté MF; Lacroix J; C-Gaudreault R; Petitclerc E
Can J Physiol Pharmacol; 2010 Nov; 88(11):1102-14. PubMed ID: 21076498
[TBL] [Abstract][Full Text] [Related]
2. Aromatic 2-chloroethyl urea derivatives and bioisosteres. Part 2: Cytocidal activity and effects on the nuclear translocation of thioredoxin-1, and the cell cycle progression.
Fortin JS; Côté MF; Lacroix J; Petitclerc E; C-Gaudreault R
Bioorg Med Chem; 2008 Aug; 16(15):7477-88. PubMed ID: 18579387
[TBL] [Abstract][Full Text] [Related]
3. Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site.
Fortin JS; Lacroix J; Desjardins M; Patenaude A; Petitclerc E; C-Gaudreault R
Bioorg Med Chem; 2007 Jul; 15(13):4456-69. PubMed ID: 17498960
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance.
Petitclerc E; Deschesnes RG; Côté MF; Marquis C; Janvier R; Lacroix J; Miot-Noirault E; Legault J; Mounetou E; Madelmont JC; C -Gaudreault R
Cancer Res; 2004 Jul; 64(13):4654-63. PubMed ID: 15231678
[TBL] [Abstract][Full Text] [Related]
5. Cycloalkyl-substituted aryl chloroethylureas inhibiting cell cycle progression in G0/G1 phase and thioredoxin-1 nuclear translocation.
Fortin JS; Côté MF; Lacroix J; Patenaude A; Petitclerc E; C-Gaudreault R
Bioorg Med Chem Lett; 2008 Jun; 18(12):3526-31. PubMed ID: 18502639
[TBL] [Abstract][Full Text] [Related]
6. Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.
Legault J; Gaulin JF; Mounetou E; Bolduc S; Lacroix J; Poyet P; Gaudreault RC
Cancer Res; 2000 Feb; 60(4):985-92. PubMed ID: 10706114
[TBL] [Abstract][Full Text] [Related]
7. Selective alkylation of beta(II)-tubulin and thioredoxin-1 by structurally related subsets of aryl chloroethylureas leading to either anti-microtubules or redox modulating agents.
Fortin JS; Côté MF; Lacroix J; Desjardins M; Petitclerc E; C-Gaudreault R
Bioorg Med Chem; 2008 Aug; 16(15):7277-90. PubMed ID: 18617414
[TBL] [Abstract][Full Text] [Related]
8. N-Phenyl-N'-(2-chloroethyl)ureas (CEU) as potential antineoplastic agents. Part 2: role of omega-hydroxyl group in the covalent binding to beta-tubulin.
Fortin S; Moreau E; Patenaude A; Desjardins M; Lacroix J; Rousseau JL; C-Gaudreault R
Bioorg Med Chem; 2007 Feb; 15(3):1430-8. PubMed ID: 17118664
[TBL] [Abstract][Full Text] [Related]
9. N-Phenyl-N'-(2-chloroethyl)ureas (CEUs) as potential antineoplastic agents. Part 3: role of carbonyl groups in the covalent binding to the colchicine-binding site.
Moreau E; Fortin S; Lacroix J; Patenaude A; Rousseau JL; C-Gaudreault R
Bioorg Med Chem; 2008 Feb; 16(3):1206-17. PubMed ID: 17998163
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of N-phenyl-N'-(2-chloroethyl)ureas in the colchicine-binding site at the interface between alpha- and beta-tubulin.
Fortin S; Wei L; Moreau E; Labrie P; Petitclerc E; Kotra LP; C-Gaudreault R
Bioorg Med Chem; 2009 May; 17(10):3690-7. PubMed ID: 19398206
[TBL] [Abstract][Full Text] [Related]
11. Intramolecular cyclization of N-phenyl N'(2-chloroethyl)ureas leads to active N-phenyl-4,5-dihydrooxazol-2-amines alkylating β-tubulin Glu198 and prohibitin Asp40.
Trzeciakiewicz A; Fortin S; Moreau E; C-Gaudreault R; Lacroix J; Chambon C; Communal Y; Chezal JM; Miot-Noirault E; Bouchon B; Degoul F
Biochem Pharmacol; 2011 May; 81(9):1116-23. PubMed ID: 21371445
[TBL] [Abstract][Full Text] [Related]
12. Oxidation and nuclear localization of thioredoxin-1 in sparse cell cultures.
Spielberger JC; Moody AD; Watson WH
J Cell Biochem; 2008 Aug; 104(5):1879-89. PubMed ID: 18384140
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the covalent binding of N-phenyl-N'-(2-chloroethyl)ureas to {beta}-tubulin: importance of Glu198 in microtubule stability.
Fortin S; Bouchon B; Chambon C; Lacroix J; Moreau E; Chezal JM; Degoul F; C-Gaudreault R
J Pharmacol Exp Ther; 2011 Feb; 336(2):460-7. PubMed ID: 20978170
[TBL] [Abstract][Full Text] [Related]
14. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
Prast-Nielsen S; Cebula M; Pader I; Arnér ES
Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
[TBL] [Abstract][Full Text] [Related]
15. A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.
Mukherjee A; Huber K; Evans H; Lakhani N; Martin S
Br J Pharmacol; 2007 Aug; 151(8):1167-75. PubMed ID: 17572693
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antiproliferative activity evaluation and structure-activity relationships of novel aromatic urea and amide analogues of N-phenyl-N'-(2-chloroethyl)ureas.
Fortin S; Moreau E; Lacroix J; Côté MF; Petitclerc E; C-Gaudreault R
Eur J Med Chem; 2010 Jul; 45(7):2928-37. PubMed ID: 20400211
[TBL] [Abstract][Full Text] [Related]
17. Redox status of thioredoxin-1 (TRX1) determines the sensitivity of human liver carcinoma cells (HepG2) to arsenic trioxide-induced cell death.
Tian C; Gao P; Zheng Y; Yue W; Wang X; Jin H; Chen Q
Cell Res; 2008 Apr; 18(4):458-71. PubMed ID: 18157160
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin fusions increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: evidence that chaperone activity is the prime effect of thioredoxin.
Jurado P; de Lorenzo V; Fernández LA
J Mol Biol; 2006 Mar; 357(1):49-61. PubMed ID: 16427080
[TBL] [Abstract][Full Text] [Related]
19. Optimized N-phenyl-N'-(2-chloroethyl)ureas as potential antineoplastic agents: synthesis and growth inhibition activity.
Moreau E; Fortin S; Desjardins M; Rousseau JL; Petitclerc E; C-Gaudreault R
Bioorg Med Chem; 2005 Dec; 13(24):6703-12. PubMed ID: 16165366
[TBL] [Abstract][Full Text] [Related]
20. New soft alkylating agents with enhanced cytotoxicity against cancer cells resistant to chemotherapeutics and hypoxia.
Patenaude A; Deschesnes RG; Rousseau JL; Petitclerc E; Lacroix J; Côté MF; C-Gaudreault R
Cancer Res; 2007 Mar; 67(5):2306-16. PubMed ID: 17332362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
